PharmaShots | Incisive News in 3 Shots

Subscribe Now

COV001

AstraZeneca's Vaxzevria (AZD1222) Delivers Strong Immune Responses in COV001 and COV002 Trials Against COVID-19

AstraZeneca's Vaxzevria (AZD1222) Delivers Strong Immune Responses in COV001 and COV002 Trials Against COVID-19

June 29, 2021

AstraZeneca and Oxford University's AZD1222 Delivers Dual Immune Response in its P-II/III COV001 Study Against COVID-19

AstraZeneca and Oxford University's AZD1222 Delivers Dual Immune Response in its P-II/III COV001 Study Against COVID-19

July 21, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us